Endothelial dysfunction and atherosclerosis

European Heart Journal

Volumn 18, Issue SUPPL.5, 1997, Pages

  Vanhoutte, P M ^a,b  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b IRIS Institut de Recherches Internationales Servier   (France)

Author keywords

Atherosclerosis; EDCFs; EDHF; EDRF; Endothelial dysfunction; G proteins

Indexed keywords

ADENOSINE DIPHOSPHATE; ARGININE; BRADYKININ; CYCLIC GMP; ENDOPEROXIDE; ENDOTHELIN; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLATE CYCLASE; LEUKOTRIENE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTACYCLIN; SEROTONIN; SUPEROXIDE; THROMBOXANE A2; VASODILATOR AGENT;

ARTERY MUSCLE; ATHEROSCLEROSIS; CONFERENCE PAPER; ENDOTHELIUM CELL; HEART MUSCLE FIBER MEMBRANE; HUMAN; HYPERPOLARIZATION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM;

ANIMALS; ARTERIOSCLEROSIS; BIOLOGICAL FACTORS; ENDOTHELINS; ENDOTHELIUM, VASCULAR; GTP-BINDING PROTEINS; HUMANS; NITRIC OXIDE;

EID: 0030723041     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(97)90005-1     Document Type: Article

References (115)

1. Furchgott RF, Zawadzki JV. The obligatory role of the endothelial cells in relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
2. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989; 3: 2007-18.
3. Lloyd-Jones DM, Bloch KD. The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med 1996; 47: 365-75.
4. Lüscher TF, Vanhoutte PM. The endothelium: modulator of cardiovascular function, Vol. FL. Boca Raton: CRC Press, 1990: 1-228.
5. Lüscher TF, Vanhoutte PM. Dysfunction of the release of endothelium-derived relaxing factor. In: Simionescu N, Simionescu M, eds. Endothelial cell dysfunction. New York: Plenum Press, 1992: 65-102.
6. Vanhoutte PM. The endothelium-modulator of vascular smooth-muscle tone. N Engl J Med 1988; 319: 512-13.
7. Vanhoutte PM. State of the art lecture: endothelium and control of vascular function. Hypertension 1989; 13: 658-67.
8. Vanhoutte PM. Hypercholesterolaemia, atherosclerosis and release of endothelium-derived relaxing factor by aggregating platelets. Eur Heart J 1991; 12 (Suppl E): 25-32.
9. Vanhoutte PM. The other endothelium-derived vasoactive factors. Circulation 1993; 87 (Suppl V): V9-V17.
10. Vanhoutte PM, Scott-Burden T. The endothelium in health and disease. Texas Heart Inst J 1994; 21: 62-7.
11. Vanhoutte PM, Shimokawa H. Endothelium-derived relaxing factor(s) and coronary vasospasm. Circulation 1989; 80: 1-9.
12. Vanhoutte PM, Gräser T, Lüscher TF. Endothelium-derived contracting factors. In: Rubanyi G, ed. Endothelin. Oxford: Oxford University Press, 1992: 3-16.
13. Vanhoutte PM, Boulanger CM, Mombouli JV. Endothelium-derived relaxing factors and converting enzyme inhibition. Am J Cardiol 1995; 76: 3E-12E.
14. Vanhoutte PM, Perrault LP, Vilaine JP. Endothelial dysfunction and vascular disease. In: Rubanyi GM, ed. The Endothelium in Clinical Practice. Marcel Dekker, 1997: 265-89.
15. Ignarro LJ, Byrns RE, Wood KS. Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical. In: Vanhoutte PM, ed. Vasodilatation: vascular smooth muscle, peptides, autonomic nerves and endothelium. New York: Raven Press, 1988: 427-36.
16. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
17. Pearson PJ, Vanhoutte PM. Vasodilator and vasoconstrictor substances produced by endothelium. Rev Physiol Biochem Pharmacol 1993; 122: 1-67.
18. Schini-Kerth VB, Vanhoutte PM. Nitric oxidc synthases in vascular cells. Exp Physiol 1995; 80: 885-905.
19. Marsden PA, Heng HHQ, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, Schappert KT. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268: 17478-88.
20. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP. Molecular cloning and characterization of the constitutive bovine aortic endothelial nitric oxide synthase. J Clin Invest 1992; 90: 2092-6.
21. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-6.
22. Busse R. Mulsch A, Fleming I, Hecker M. Mechanisms of nitric oxide release from the vascular endothelium. Circulation 1993; 87: V18-V25.
23. Ayajiki K, Kindermann M, Hecker M, Fleming I, Busse R. Intracelluar pH and tyrosine phosphorylation but not calcium determine shear-stress-induced nitric oxide production in native endothelial cells. Circ Res 1996; 78: 750-8.
24. Corson MA, James NL, Latta SE, Nerem RM, Berk BC, Harrison DG. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res 1996; 79: 984-91.
25. Rapoport RM, Murad F. Agonist-induced endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP. Circ Res 1983; 52: 352-7.
26. Vane JR. The endothelium: maestro of the blood circulation. Phil Trans R Soc Lon B 1994; 348: 225-46.
27. Scott-Burden T, Vanhoutte PM. The endothelium as a regulator of vascular smooth muscle proliferation. Circulation 1993; 87 (Suppl V): V51-V55.
28. Scott-Burden T, Vanhoutte PM. Regulation of smooth muscle cell growth by endothelium-derived factorts. Texas Heart Inst J 1994; 21: 91-7.
29. Bassenge E, Heuch G. Endothelial and neuro-humoral control of coronary blood flow in health and disease. Rev Physiol Biochem Pharmacol 1990; 116: 79-163.
30. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986; 250: H1145-H1149.
31. + and barium. In: Mulvany MJ, ed. Resistance arteries. Structure and function. New York: Elsevier, 1991: 226-32.
32. Vanhoutte PM, Boulanger CM. Endothelium-dependent responses in hypertension. Hypertens Res Clin Exp 1995; 18: 87-98.
33. Shimokawa H, Flavahan NA, Vanhoutte PM. Natural course of the impairment of endothelium-dependent relaxations after balloon endothelial removal in porcine coronary arteries. Possible dysfunction of a pertussis toxin-sensitive G protein. Circ Res 1989; 65: 740-53.
34. Boulanger CM, Vanhoutte PM. G-proteins and endothelium-dependent relaxations. J Vascular Res 1997: 34: 175-85.
35. Flavahan NA, Vanhoutte PM. G-protein and endothelial responses. Blood Vessels 1990; 27: 218-29.
36. Flavahan NA, Vanhoutte PM. Endothelial cell signaling and endothelial dysfunction. Am J Hypertens 1995; 8: 28S-41S.
37. Shibano T, Godina J, Birnbaumer L, Vanhoutte PM. Pertussis toxin-sensitive G-proteins in regenerated endothelial cells after balloon denudation of porcine coronary artery. Am J Physiol 1994; 267: H979-H981.
38. Freeman JE, Kuo WY, Milligan G, Lowenstein CJ, Levine MA, Flavahan NA. Analysis of the pertussis toxin-sensitive receptor: G-protein interactions in native porcine endothelial cells. Endothelium 1995; 3: 321-30.
39. Ohno M, Gibbons GH, Dzau VJ, Cooke JP. Shear stress elevates endothelial cGMP: role of a potassium channel and G-protein coupling. Circulation 1993; 88: 193-7.
40. Nakaike R, Shimokawa H, Owada MK, Tokunaga O, Yasutake H, Kishimoto T, Imada C, Shiraishi T, Egashira K, Takeshita A. Vanadate causes synthesis of endothelium-derived NO via pertussis toxin-sensitive G protein in pigs. Am J Physiol 1996; 271: H296-H302.
41. alphaq family couple the bradykinin receptor to the release of endothelium-derived relaxing factor. J Clin Invest 1993; 92: 2168-72.
42. Frangos JA, Huang TY, Clark CB. Steady shear and step changes in shear stimulate endothelium via independent mechanisms -superposition of transient and sustained nitric oxide production. Biochem Biophys Res Comm 1996; 224: 660-5.
43. Houston DS, Vanhoutte PM. Platelets and endothelium-dependent responses. In: Vanhoutte PM, ed. Relaxing and contracting factors: biological and clinical research. Clifton NJ: Humana Press, 1988: 425-49.
44. Parsaee H, McEwan JR, Sunil J, McDermot J. Differential sensitivities of the prostacylcin and nitric oxide biosynthetic pathways to cytosolic calcium in bovine aortic endothelial cells. Br J Pharmacol 1992; 107: 1013-19.
45. Berthiaume F, Frangos JA. Flow-induced prostacyclin production is mediated by a pertussis toxin-sensitive G protein. FEBS Letters 1992; 308: 277-9.
46. Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostcyclin. Pharmacol Rev 1979; 30: 293-331.
47. Félétou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 1988; 93: 515-24.
48. Vanhoutte PM. Endothelium-derived hyperpolarizing factor. The Netherlands: Harwood Academic publishers, 1996.
49. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing. Circ Res 1996; 78: 415-23.
50. Komori K, Vanhoutte PM. Endothelium-derived hyperpolarizing factor. Blood Vessels 1990; 27: 238-45.
51. Nagao T, Vanhoutte PM. Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations. Am J Respir Cell Mol Biol 1993; 8: 1-6.
52. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation 1995; 92: 3337-49.
53. Taylor SG, Weston AH. Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci 1988; 9: 272-4.
54. Nakashima M, Mombouli JV, Taylor AA, Vanhoutte PM. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest 1993; 92: 2867-71.
55. Kilpatrick EV, Cocks TM. Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery. Br J Pharmacol 1994; 112: 557-65.
56. de Mey JG, Vanhoutte PM. Heterogenous behavour of the canine arterial and venous wall: importance of the endothelium. Circ Res 1982; 5: 439 47.
57. Rubanyi GM, Vanhoutte PM. Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. J Physiol 1985; 364: 45-56.
58. Vanhoutte PM. Is endothelin involved in the pathogenesis of hypertension? Hypertension 1993; 21: 747-51.
59. Vanhoutte PM, Rubanyi GM, Miller VM, Houston DS. Modulation of vascular smooth muscle contraction by the endothelium. Ann Rev Physiol 1986; 48: 307-20.
60. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor(s). Am J Physiol 1986; 250: H822-H827.
61. Yanagisawa M, Kurihara H, Kimura S, Tonobe Y, Kobayashi M, Mitsui Y, Yasaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-15.
62. Masaki T, Yanagisawa M, Goto K. Physiology and pharmacology of endothelins. Med Res Rev 1992; 12: 391-421.
63. Sakurai S, Goto K. Endothelins. Vascular actions and clinical implications. Drugs 1993; 46: 795-804.
64. Schini VB, Vanhoutte PM. Endothelin-1: a potent vasoactive peptide. Pharmacol Toxicol 1991; 69: 1-7.
65. Lüscher TF, Oemar BS, Boulanger CM, Hahn AWA. Molecular and cellular biology of endothelin and its receptors. In: Lindpainter K, Ganten D, eds. Molecular reviews in cardiovascular medicine. London: Chapman and Hall, 1996: 96-104.
66. Gerhard M, Roddy MA, Creager SJ, Creager MA. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996; 27: 849-53.
67. Gohra H, McDonald TO, Verrier ED, Aziz S. Endothelial loss and regeneration in a model of transplant arteriosclerosis. Transplantation 1995; 60: 96-102.
68. Shimokawa H, Aarhus LL, Vanhoutte PM. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ Res 1987; 61: 256-70.
69. Borg-Capra C, Fournet-Bourguignon MP, Janiak P, Villeneuve N, Bidouard JP, Vilaine JP, Vanhoutte PM. Morphological heterogeneity with normal expression but altered function of Gi proteins in cultured regenerated porcine coronary endothelial cells. FASEB J 1996; 10: A602.
70. Shimokawa H, Vanhoutte PM. Angiographic demonstration of hyperconstriction induced by serotonin and aggregating platelets in porcine coronary arteries with regenerated endothelium. J Am Coll Cardiol 1991; 17: 1197-202.
71. Day NS, Ge T, Codina J, Birnbaumer L, Vanhoutte PM, Boulanger CM. Gi proteins and the response to 5-hydroxytryptamine in porcine cultured endothelial cells with impaired release of EDRF. Br J Pharmacol 1995; 115: 822-7.
72. Shimokawa H, Vanhoutte PM. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ Res 1989; 64: 900-14.
73. Shimokawa H, Flavahan NA, Vanhoutte PM. Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries. Circulation 1991; 83: 652-60.
74. Kolodgie FD, Virmani R, Rice HE et al. Vascular reactivity during the progression of atherosclerotic plaque. A study of Watanable heritable hyperlipidemic rabbits. Circ Res 1990; 66: 1112-26.
75. Kuo L, Davies MJ, Cannon MS et al. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation. Circ Res 1992; 70: 465-76.
76. Sellke FW, Armstrong ML, Harrison DG. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circuatoin 1990; 81: 1586-93.
77. Mano T, Masuyama T, Yamamoto K, Naito J, Kondo H, Nagano R, Tanouchi J, Hori M, Inoue M, Kamada T. Endothelial dysfunction in the early stage of atheroscslerosis precedes appearance of intimai lesions assessable with intravascular ultrasound. Am Heart J 1996; 131: 231-8.
78. Gollino P, Piscione F, Willerson JT et al. Divergent effects of serotonin on coronary artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med 1991; 324: 641-8.
79. Cox DA, Vita JA, Treasure CB et al. Atherosclerosis impairs flow-mediated dilation of coronary arteries of humans. Circulation 1989; 80: 458-65.
80. Drexler H, Zeiher AM, Wollschlager H et al. Flow dependent coronary artery dilatation in humans. Circulation 1989; 80: 466-74.
81. Gordon JB, Ganz P, Nabel EG et al. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. J Clin Invest 1989; 83: 1946-52.
82. McLenachan JM, Williams JK, Fish RD et al. Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis. Circulation 1991; 84: 1273-8.
83. Nabel EG, Ganz P, Gordon JB et al. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 1988; 77: 43-52.
84. Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsible for changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol 1990; 16: 349-56.
85. Vita JA, Treasure CB, Ganz P et al. Control of shear stress in the epicardial coronary arteries of humans: impairment by atherosclerosis. J Am Coll Cardiol 1989; 14: 1193-9.
86. Vita JA, Treasure CB, Nabel EG et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491-7.
87. Yeung AC, Vekshtein VI, Krantz DS et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 1991; 325: 1551-6.
88. Zeiher AM, Drexler H, Wollschlager H et al. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol 1989; 14: 1181-90.
89. Zeiher AM, Drexler HD, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83: 391-401.
90. Bossaller C, Habib GB, Yamamoto H et al. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation on an atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 1987; 79: 170-4.
91. Förstermann U, Müdge A, Alheid U et al. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res 1988; 62: 185-90.
92. Ludmer PL, Selwyn AP, Shook TL et al Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046-51.
93. Collins P, Burman J, Chung HI et al. Hemoglobin inhibits endothelium-dependent relaxation to acetylcholine in human coronary arteries in vivo. Circulation 1993; 87: 80-5.
94. Hodgson JM, Marshall JJ. Direct vasoconstriction and endothelium-dependent vasodilation: mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation 1989; 79: 1043-51.
95. Lefroy DC, Crake T, Uren NG et al. Effect of inhibition of NO synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation 1993; 88: 43-54.
96. Reddy KG, Nair R, Sheehan HM el al. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 1994; 23: 883-43.
97. Heitzer T, Ylä-Herttuala S, Luoma J, Kurz S, Münzel T, Just M, Olschewski M, Drexler H. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 1996; 93: 1346-53.
98. McLenachan JM, Vita J, Fish DR et al. Early evidence of endothelial vasodilator dysfunction at coronary branch points. Circulation 1990; 82: 1169-73.
99. Tsurumi Y, Nagashima H, Ichikawa KI, Sumiyoshi T, Hosoda S. Influence of plasma lipoprotein(a) levels on coronary vasomotor response to acetylcholine. J Am Coll Cardiol 1995; 26: 1242-50.
100. Anderson TJ, Meredith IT, Charbonneau F, Yeung AC, Frei B, Selwyn AP, Ganz P. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation 1996; 93: 1647-50.
101. Creager MA, Cooke JP, Mendelsohn ME et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990; 86: 228-34.
102. Celermajer DS, Soresnsen KE, Gooch VM et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-15.
103. Drexler H, Zeiher AM, Meinzer K et al. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet 1991; 338: 1546-50.
104. Creager MA, Roddy MA, Coleman SM, Dzau VJ. The effect of ACE inhibition on endothelium-dependent vasodilatation in hypertension. J Vasc Res 1992; 29: 97-8.
105. Anderson TJ, Uehata A, Gerhard M, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995: 26: 1235-41.
106. Harrison DG. Alteration of vasomotor regulation in atherosclerosis. Cardiovassc Drugs Ther 1995; 9: 55-63.
107. Cooke JP, Andon NA, Girerd XJ et al. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit aorta. Circulation 1991; 83: 1057-62.
108. Girerd XJ, Hirsch AT, Cooke JP et al. Arginine augments endothelium-dependent vasodilatation in cholesterol-fed rabbit. Circ Res 1990; 67: 1301-8.
109. Cox DA, Cohen ML. Effects of oxidized low density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis. Pharmacol Rev 1996; 48: 3-19.
110. Liao JK, Clark SL. Regulation of G-proteins alpha2i subunit expression by oxidized low density lipoprotein. J Clin Invest 1995; 95: 1457-63.
111. Flavahan NA. Lysophosphatidylcholine modifies G-proteins-dependent signaling in porcine endothelial cells. Am J Physiol 1993; 264: H722-H727.
112. Tsutsui M, Shimokawa H, Tanaka S, Kuwaoka I, Hase K. Nogami N, Nakanishi K, Okamatsu S. Endothelial Gi protein in human coronary arteries. Eur Heart J 1994; 15: 1261-6.
113. Shimokawa H, Tsutsui M, Mizuki T. Hase K, Kuwaoka I, Nogani N, Okamatsu S, Nakanishi K. Endothelial Gi protein expression is markedly low in human coronary microvessels. J Cardiovasc Pharmacol 1996; 27: 297-302.
114. Liao JK, Shin WS, Lee WY, Clark SL. Oxidized low-density lipoproteins decrease the expression of endothelial nitric oxide synthase. J Biol Chem 1995; 270: 319-24.
115. Boulanger CM, Tanner FC, Bea ML, Werner A, Hahn AWA, Lüscher TF. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 1992; 70: 1191-7.